These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7798459)

  • 21. Serum endotoxin, tumor necrosis factor, and interleukin-6 response to total hip arthroplasty.
    Wilson KW; Wilson MR; McGlasson DL
    Mil Med; 1993 Nov; 158(11):712-6. PubMed ID: 8284058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
    Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
    Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis.
    Tanaka H; Ishikawa K; Nishino M; Shimazu T; Yoshioka T
    J Trauma; 1996 May; 40(5):718-25; discussion 725-6. PubMed ID: 8614069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin release and cytokine production in acute and chronic meningococcaemia.
    Prins JM; Lauw FN; Derkx BH; Speelman P; Kuijper EJ; Dankert J; van Deventer SJ
    Clin Exp Immunol; 1998 Nov; 114(2):215-9. PubMed ID: 9822279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trauma with septicemia. Time to reevaluate treatment with antibiotics?].
    Nyström PO
    Lakartidningen; 1990 Sep; 87(39):3057-8, 3063-4. PubMed ID: 2215019
    [No Abstract]   [Full Text] [Related]  

  • 26. Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.
    Spinas GA; Bloesch D; Keller U; Zimmerli W; Cammisuli S
    J Infect Dis; 1991 Jan; 163(1):89-95. PubMed ID: 1984481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CORRELATION OF RED BLOOD FACTORS IN POLYTRAUMA INDUCED SEPSIS AND SEPTIC SHOCK PATIENTS.
    Kanashvili B; Saganelidze K; Ratiani L
    Georgian Med News; 2018 Sep; (282):82-87. PubMed ID: 30358546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor necrosis factor, interleukin-6, endotoxin and procalcitonin in septic shock in patients with hematologic neoplasms].
    Galstian GM; Berkovskiĭ AL; Zueva VA; Kariakin AV; Levina AA; Sergeeva EV; Speranskaia LL; Gorodetskiĭ VM
    Ter Arkh; 2002; 74(7):56-61. PubMed ID: 12181838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
    Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
    Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Kurtogglu S; Caksen H; Hallaç IK; Ustünbas HB; Uzüm K; Kiliç H
    Pediatr Emerg Care; 2003 Jun; 19(3):219-20. PubMed ID: 12813315
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
    Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW
    J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin-induced cytokines in human septicemia.
    de Vries I; van Deventer SJ; Debets J; Buller HR; ten Cate JW; Pauw W; Statius van Eps LW; Sturk A
    Adv Exp Med Biol; 1990; 256():635-40. PubMed ID: 2327306
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic and liver cytokine activation. Implications for liver regeneration and posthepatectomy endotoxemia and sepsis.
    Enayati P; Brennan MF; Fong Y
    Arch Surg; 1994 Nov; 129(11):1159-64. PubMed ID: 7979948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
    Dofferhoff AS; Bom VJ; de Vries-Hospers HG; van Ingen J; vd Meer J; Hazenberg BP; Mulder PO; Weits J
    Crit Care Med; 1992 Feb; 20(2):185-92. PubMed ID: 1371097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
    Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
    Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis.
    Flach R; Majetschak M; Heukamp T; Jennissen V; Flohé S; Börgermann J; Obertacke U; Schade FU
    Cytokine; 1999 Feb; 11(2):173-8. PubMed ID: 10089141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines and acute-phase response markers derangements in patients with obstructive jaundice.
    Padillo FJ; Andicoberry B; Muntane J; Lozano JM; Miño G; Sitges-Serra A; Solorzano G; Pera-Madrazo C
    Hepatogastroenterology; 2001; 48(38):378-81. PubMed ID: 11379313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group.
    Goldie AS; Fearon KC; Ross JA; Barclay GR; Jackson RE; Grant IS; Ramsay G; Blyth AS; Howie JC
    JAMA; 1995 Jul; 274(2):172-7. PubMed ID: 7596007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole blood tumor necrosis factor-alpha production and its relation to systemic concentrations of interleukin 4, interleukin 10, and transforming growth factor-beta1 in multiply injured blunt trauma victims.
    Majetschak M; Börgermann J; Waydhas C; Obertacke U; Nast-Kolb D; Schade FU
    Crit Care Med; 2000 Jun; 28(6):1847-53. PubMed ID: 10890631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.